Janus Henderson Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-480,665
Closed -$157M 2603
2024
Q1
$157M Sell
480,665
-21,068
-4% -$5.17M 0.09% 209
2023
Q4
$95.6M Buy
501,733
+182,651
+57% +$34.5M 0.06% 260
2023
Q3
$63.5M Buy
319,082
+68,923
+28% +$16.3M 0.04% 318
2023
Q2
$71.4M Sell
250,159
-16,055
-6% -$4.46M 0.04% 318
2023
Q1
$57.7M Buy
266,214
+259,754
+4,021% +$50.6M 0.04% 349
2022
Q4
$1.33M Sell
6,460
-342
-5% -$86.5K ﹤0.01% 1227
2022
Q3
$1.89M Sell
6,802
-190
-3% -$48.3K ﹤0.01% 1331
2022
Q2
$1.34M Buy
6,992
+716
+11% +$126K ﹤0.01% 1197
2022
Q1
$1.3M Buy
6,276
+2
+0% +$330 ﹤0.01% 1393
2021
Q4
$1.12M Buy
6,274
+3,158
+101% +$623K ﹤0.01% 1466
2021
Q3
$641K Buy
+3,116
New +$612K ﹤0.01% 1509

Other funds holding SWAV

Janus Henderson Group's SWAV Position: Q2 2024 in Review

Janus Henderson Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 480,665 shares — an estimated $157M sold.

Janus Henderson Group first reported a position in SWAV in Q3 2021 and held it in 11 quarters. The position peaked at $157M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Janus Henderson Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Janus Henderson Group sold 480,665 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $157M.
  • Janus Henderson Group first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Janus Henderson Group's Shockwave Medical, Inc. Common Stock position peaked at $157M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.